A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma

BACKGROUND. We assessed the efficacy and safety of bevacizumab (BEV) through multiple lines in patients with recurrent glioblastoma who had progressed after first‐line treatment with radiotherapy, temozolomide, and BEV. PATIENTS AND METHODS. TAMIGA (NCT01860638) was a phase II, randomized, double‐bl...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncologist
Main Authors: Brandes, Alba A., Gil‐Gil, Miguel, Saran, Frank, Carpentier, Antoine F., Nowak, Anna K., Mason, Warren, Zagonel, Vittorina, Dubois, François, Finocchiaro, Gaetano, Fountzilas, George, Cernea, Dana Michaela, Chinot, Oliver, Anghel, Rodica, Ghiringhelli, Francois, Beauchesne, Patrick, Lombardi, Giuseppe, Franceschi, Enrico, Makrutzki, Martina, Mpofu, Chiedzo, Urban, Hans‐Joerg, Pichler, Josef
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Inc. 2018
Fag:
Neuro‐Oncology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6459244/
https://ncbi.nlm.nih.gov/pubmed/30266892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0290
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker